Gilead Sciences Allowance for doubtful accounts increased by 7.3% to $44.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 25.4%, from $59.00M to $44.00M. Over 5 years (FY 2020 to FY 2025), Allowance for doubtful accounts shows relatively stable performance with a -1.4% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increasing allowance relative to receivables may signal deteriorating customer credit quality or a weakening economic environment.
This is a contra-asset account that represents the estimated portion of accounts receivable that the company does not ex...
Standard accounting practice; peers in similar industrial sectors typically maintain reserves proportional to their credit risk profile.
other_allowance_for_doubtful_accounts_receivable_current| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $57.00M | $57.00M | $47.00M | $54.00M | $51.00M | $51.00M | $55.00M | $56.00M | $59.00M | $54.00M | $56.00M | $59.00M | $60.00M | $65.00M | $52.00M | $59.00M | $50.00M | $41.00M | $41.00M | $44.00M |
| QoQ Change | — | +0.0% | -17.5% | +14.9% | -5.6% | +0.0% | +7.8% | +1.8% | +5.4% | -8.5% | +3.7% | +5.4% | +1.7% | +8.3% | -20.0% | +13.5% | -15.3% | -18.0% | +0.0% | +7.3% |
| YoY Change | — | — | — | — | -10.5% | -10.5% | +17.0% | +3.7% | +15.7% | +5.9% | +1.8% | +5.4% | +1.7% | +20.4% | -7.1% | +0.0% | -16.7% | -36.9% | -21.2% | -25.4% |